Methods of inducing cancer cell death and tumor regression using a FTP inhibitor and a tyrosine kinase inhibitor

摘要

Described are products containing the FPT inhibitor (formula I) and the tyrosine kinase inhibitor (formula II) as a combined preparation for simultaneous, separate or sequential use in the treatment of diseases such as lung cancer, pancreatic cancer, myelodysplastic syndrome and glioma.